U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Reduced insulin like growth factor binding protein acid labile subunit concentration

MedGen UID:
1390100
Concept ID:
C4321359
Finding
Synonyms: Acid-labile subunit deficiency; Decreased levels of acid labile subunit; Reduced insulin like growth factor binding protein acid labile subunit level
 
HPO: HP:0045046

Definition

An abnormally decreased concentration of insulin like growth factor binding protein acid labile subunit level in the blood circulation. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVReduced insulin like growth factor binding protein acid labile subunit concentration

Conditions with this feature

Short stature due to primary acid-labile subunit deficiency
MedGen UID:
859716
Concept ID:
C3900122
Laboratory or Test Result
Acid-labile subunit deficiency is characterized by severely reduced serum insulin-like growth factor I (IGF1; 147440) and IGF-binding protein-3 (IGFBP3; 146732) concentrations that are incongruent with an associated mild growth retardation (height, -2 to -3 SD before and during puberty). Pubertal delay in boys and insulin insensitivity are common findings (summary by Domene et al., 2011).

Professional guidelines

PubMed

Limal JM, Parfait B, Cabrol S, Bonnet D, Leheup B, Lyonnet S, Vidaud M, Le Bouc Y
J Clin Endocrinol Metab 2006 Jan;91(1):300-6. Epub 2005 Nov 1 doi: 10.1210/jc.2005-0983. PMID: 16263833

Recent clinical studies

Therapy

Limal JM, Parfait B, Cabrol S, Bonnet D, Leheup B, Lyonnet S, Vidaud M, Le Bouc Y
J Clin Endocrinol Metab 2006 Jan;91(1):300-6. Epub 2005 Nov 1 doi: 10.1210/jc.2005-0983. PMID: 16263833
Van den Berghe G, Baxter RC, Weekers F, Wouters P, Bowers CY, Veldhuis JD
J Clin Endocrinol Metab 2000 Jan;85(1):183-92. doi: 10.1210/jcem.85.1.6316. PMID: 10634385
Van den Berghe G
Horm Res 1999;51 Suppl 3:21-8. doi: 10.1159/000053158. PMID: 10592440
Kee AJ, Baxter RC, Carlsson AR, Smith RC
Am J Physiol 1999 Jul;277(1):E63-72. doi: 10.1152/ajpendo.1999.277.1.E63. PMID: 10409129
Higaki K, Matsumoto Y, Fujimoto R, Kurosaki Y, Kimura T
Drug Metab Dispos 1997 Nov;25(11):1324-7. PMID: 9351911

Prognosis

Hoogwerf D, van Doorn J, Maartense E
Ann Clin Biochem 2013 Mar;50(Pt 2):169-72. Epub 2013 Mar 6 doi: 10.1258/acb.2012.012125. PMID: 23467067
Barrios V, Argente J, Muñoz MT, Pozo J, Chowen JA, Hernández M
Eur J Endocrinol 2001 Mar;144(3):245-50. doi: 10.1530/eje.0.1440245. PMID: 11248743
Van den Berghe G
Horm Res 1999;51 Suppl 3:21-8. doi: 10.1159/000053158. PMID: 10592440

Clinical prediction guides

Aguiar-Oliveira MH, Souza AHO, Oliveira CRP, Campos VC, Oliveira-Neto LA, Salvatori R
Eur J Endocrinol 2017 Aug;177(2):R85-R97. Epub 2017 Apr 20 doi: 10.1530/EJE-16-1047. PMID: 28428227
Limal JM, Parfait B, Cabrol S, Bonnet D, Leheup B, Lyonnet S, Vidaud M, Le Bouc Y
J Clin Endocrinol Metab 2006 Jan;91(1):300-6. Epub 2005 Nov 1 doi: 10.1210/jc.2005-0983. PMID: 16263833
Domené HM, Bengolea SV, Jasper HG, Boisclair YR
J Endocrinol Invest 2005;28(5 Suppl):43-6. PMID: 16114275
Garrone S, Radetti G, Sidoti M, Bozzola M, Minuto F, Barreca A
J Clin Endocrinol Metab 2002 Dec;87(12):5455-60. doi: 10.1210/jc.2002-020614. PMID: 12466336
Bang P, Brismar K, Rosenfeld RG
J Clin Endocrinol Metab 1994 May;78(5):1119-27. doi: 10.1210/jcem.78.5.7513716. PMID: 7513716

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...